RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions

Thyroid Cancer

Interventions

DRUG

RET Inhibitor

RET inhibitors for neoadjuvant treatment

PROCEDURE

Surgery

Operable patients receive surgery after neoadjuvant therapy

Trial Locations (1)

RECRUITING

Fudan Univeristy Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER